QLT Inc. today announced that its wholly-owned U.S. subsidiary, QLT Ophthalmics, Inc. (“QOI”), and Quantel Medical and its distributor, Quantel USA, Inc., have entered into a co-promotion agreement for the sale of Activis PDT Lasers used to activate Vi…
Month: November 2010
Current Understanding and Management of Giant Cell Arteritis and Polymyalgia Rheumatica
This article reviews recent guidelines on early diagnosis, investigations and management of these two diseases impacting the elderly. Expert Review of Clinical Immunology
Angle Abnormalities, Heterochromia Iridis May Play Role In Glaucoma Development In Sturge-Weber Syndrome
Anterior chamber angle abnormalities and heterochromic iridis may be linked to the development of glaucoma in infants with Sturge-Weber syndrome, according to a study.
Moving SLT Procedures to the ASC
Technology Spotlight
Future Bleak For New Antibiotic Development
The field of medicine in general, and ophthalmology in particular, has seen a dramatic slowdown in the development of novel antibiotics, and the immediate future appears to offer no real promise.
Future Bleak For New Antibiotic Development
The field of medicine in general, and ophthalmology in particular, has seen a dramatic slowdown in the development of novel antibiotics, and the immediate future appears to offer no real promise.
Angle Abnormalities, Heterochromia Iridis May Play Role In Glaucoma Development In Sturge-Weber Syndrome
Anterior chamber angle abnormalities and heterochromic iridis may be linked to the development of glaucoma in infants with Sturge-Weber syndrome, according to a study.
Future Bleak For New Antibiotic Development
The field of medicine in general, and ophthalmology in particular, has seen a dramatic slowdown in the development of novel antibiotics, and the immediate future appears to offer no real promise.
Future Bleak For New Antibiotic Development
The field of medicine in general, and ophthalmology in particular, has seen a dramatic slowdown in the development of novel antibiotics, and the immediate future appears to offer no real promise.
Future Bleak For New Antibiotic Development
The field of medicine in general, and ophthalmology in particular, has seen a dramatic slowdown in the development of novel antibiotics, and the immediate future appears to offer no real promise.
Commercialization Of The Most Promising Research At BGU
A Los Angeles philanthropist has created an innovative foundation model that will provide up to $1.2 million to help fund and commercialize research at Ben-Gurion University of the Negev in Beer-Sheva, Israel…
More Than 72,000 Clinical Photographs Illustrate Age-Related Eye Disease Progression
The National Institutes of Health has expanded a genetic and clinical research database to give researchers access to the first digital study images…
How Effective Are AMD Drugs in Treating Diabetic Macular Edema?
At the AAO meeting in October, researchers reported that anti-VEGF drugs such as ranibizumab (Lucentis) and pegaptanib (Macugen) also appeared to be effective in improving visual acuity in patients with diabetic macular edema in a series of randomized, controlled trials.
Flexivue and AcuFocus Among New Options That May Eliminate Need for Reading Glasses
The following new technologies were reviewed at the AAO meeting in October 2010 for addressing presbyopia : an intracorneal bifocal corrective lens called Flexivue from Presbia Corp., which is inserted under the cornea; an implant called AcuFocus that that reduces the…
Tallis PR: Ophthalmos Collects Platinum Award For Lens-Free Ophthalmoscope
New screening device wins at Nursing Times Product Awards Optyse™, the lens-free ophthalmoscope has been recognised with a Platinum Award in the Patient Observation category at the inaugural Nursing Times Product Awards…
Company Profile for Iris Pharma
–(BUSINESS WIRE)–Iris Pharma is an independent Contract Research Organization (CRO), dedicated to preclinical and clinical research in ophthalmology.
University Study Points To Method Of Reversing Age-Related Decline In Vision
Elderly adults can improve their vision with perceptual training, according to a study from the University of California, Riverside and Boston University that has implications for the health and mobility of senior citizens. The study, “Perceptual learn…
Scleral Spacing Procedures Showing Restoration Of Accommodation
While they have been slow to gain wide acceptance in the ophthalmology community, scleral spacing procedures have shown the ability to restore accommodation in presbyopic eyes, according to one presenter here.
Less-Frequent Injected Drug Works in Wet Macular Degeneration
Regeneron Pharmaceuticals Inc’s treatment for wet macular degeneration was as effective and safe in two late-stage trials as Roche Holding AG’s blockbuster Lucentis, with half the number of eye injections. Reuters Health Information
Research and Markets: Premium Intraocular Lenses (IOLs) Market: Trends and Future Outlook
DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of GlobalData’s new report “Premium Intraocular Lenses (IOLs) Market: Trends and Future Outlook” to their offering. The report provides key data, information and analysis on the global premium IOLs market.